Sabi-ur Rehman

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis

H. Faidah, S. Rehman, Saad Alghamdi, 2020, Molecules.

Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches

Salman Khan, S. Rehman, S. Khan, 2022, Molecules.

COVID-19 challenges and its therapeutics

S. Rehman, Hye-Hyun Yoo, Sabi-ur Rehman, 2021, Biomedicine & Pharmacotherapy.

A case report of unexplained persistent conjugated hyperbilirubinemia with normal liver transaminases over 23 years: remember Dubin-Johnson syndrome!

Safeer Khan, Sabi-ur Rehman, Danish Ali, 2023, Journal of Rare Diseases.